These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29333468)

  • 21. Idiopathic Hepatic and Splenic Uptake of
    Kalimuthu LM; Nazar AH; Pradhan PK
    Indian J Nucl Med; 2020; 35(3):238-240. PubMed ID: 33082683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extraosseous
    Verma S; Kumar N; Kheruka SC; Gambhir S
    Indian J Nucl Med; 2016; 31(4):280-282. PubMed ID: 27833313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual visceral distribution of technetium-99m-methylene diphosphonate in a case of hypercalcemia of malignancy.
    Shimpi MM; Singh N; Gupta N
    Indian J Nucl Med; 2016; 31(1):67-8. PubMed ID: 26917902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer.
    Kawase T; Fujii H; Nakahara T; Shigematsu N; Kubo A; Kosuda S
    Clin Nucl Med; 2009 Mar; 34(3):173-4. PubMed ID: 19352284
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Liu S; Xie J; Yu F; Cai H; Wu F; Zheng H; Ma C; Lv Z; Wang H
    Cancer Manag Res; 2020; 12():2449-2457. PubMed ID: 32308481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher's disease.
    Mariani G; Molea N; La Civita L; Porciello G; Lazzeri E; Ferri C
    Eur J Nucl Med; 1996 Apr; 23(4):466-70. PubMed ID: 8612670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer.
    Alexiou E; Georgoulias P; Valotassiou V; Georgiou E; Fezoulidis I; Vlychou M
    Hell J Nucl Med; 2015; 18(1):77-8. PubMed ID: 25679079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible Tc-99m diphosphonate uptake in gastric tissue associated with malignancy related hypercalcemia. A comparative study using PET FDG whole body imaging.
    Meyer MA; McClaughry P
    Clin Nucl Med; 1995 Sep; 20(9):767-9. PubMed ID: 8521650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of massive technetium-99m methylene diphosphonate uptake in the stomach in vitamin D intoxication.
    Corstens F; Kerremans A; Claessens R
    J Nucl Med; 1986 Feb; 27(2):219-22. PubMed ID: 3012022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
    Gedik GK; Ata O; Karabagli P; Sari O
    Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidentally detected cardiac amyloidosis on
    Fathala A
    Radiol Case Rep; 2020 Jun; 15(6):705-708. PubMed ID: 32280403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse Myocardial Uptake of (99m)Tc-HDP in Multiple Myeloma.
    Demirel K; Sadic M; Korkmaz M; Comak A; Atilgan HI; Koca G
    Nucl Med Mol Imaging; 2013 Sep; 47(3):208-11. PubMed ID: 24900110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extraosseous uptake of technetium-99m methylene diphosphonate by an acute territorial cerebral infarct in a classical biodistribution pattern.
    Kannivelu A; Padhy AK; Srinivasan S; Ali SZ
    Indian J Nucl Med; 2013 Oct; 28(4):240-2. PubMed ID: 24379538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse hepatic and splenic Tc-99m MDP tracer uptake in case of multiple myeloma.
    Sood A; Seam RK; Sethi S; Gupta M
    Indian J Nucl Med; 2010 Apr; 25(2):70-2. PubMed ID: 21188069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia.
    Kekilli E; Yagmur C; Kuzucu A; Soysal O; Cikim AS; Ertem K
    Ann Nucl Med; 2004 Oct; 18(7):627-30. PubMed ID: 15586638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What causes uptake of technetium-99m methylene diphosphonate by tumors? A case where the tumor appeared to secrete a hypercalcemia-causing substance.
    Stone CK; Sisson JC
    J Nucl Med; 1985 Mar; 26(3):250-3. PubMed ID: 3156221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.